🏛️ Verified NIH Record • Updated 2026-08-10
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults (NCT07496450)
A Phase 3, Randomized, Observer-blind, Placebo-controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of mRNA-1018-H5 Pandemic Influenza Vaccine in Adults ≥18 Years of Age
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: ModernaTX, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.
Who can join: Review the eligibility criteria below.
Location: Velocity Clinical Research, San Bernardino — San Bernardino, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (35 Sites)
Showing the first 25 of 35 sites.
- Velocity Clinical Research, San Bernardino — San Bernardino, California
- Velocity Clinical Research, Savannah — Savannah, Georgia
- Velocity Clinical Research, Boise — Meridian, Idaho
- Velocity Clinical Research, Rockville — Rockville, Maryland
- Velocity Clinical Research, Omaha — Omaha, Nebraska
- Velocity Clinical Research, Cleveland — Beachwood, Ohio
- Velocity Clinical Research, Providence — East Greenwich, Rhode Island
- Velocity Clinical Research, Anderson — Anderson, South Carolina
- Velocity Clinical Research, Dallas — Dallas, Texas
- Velocity Clinical Research, Suffolk — Suffolk, Virginia
- Velocity Clinical Research-Bristol — Bristol, Bristol (Unitary Authority)
- Velocity Clinical Research - High Wycombe — High Wycombe, Buckinghamshire
- Wansford Research Ltd — Peterborough, Cambridgeshire
- Futuremeds Teesside Middlefield Centre University Hospital of North Tees — Stockton-on-Tees, County Durham
- NIHR Wessex CRDC - Bournemouth Research Hub (Under University Hospital Southampton NHS Foundation Trust) — Bournemouth, Dorset
- NIHR Wessex CRDC - Weymouth Research Hub (Under University Hospital Southampton NHS Foundation Trust) — Weymouth, Dorset
- Panthera Glasgow — Glasgow, Glasgow City (Scotland)
- Panthera Enfield — Enfield, Greater London
- Hounslow Medical Centre — Hounslow, Greater London
- hVIVO Services Limited — London, Greater London
- Velocity Clinical Research-North London — London, Greater London
- Accellacare North London — Northwood, Greater London
- Accellacare South London — Orpington, Greater London
- Velocity Clinical Research-Romford — Romford, Greater London
- Panthera Rochdale — Rochdale, Greater Manchester
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Influenza
- Kaiser Colorado Flu Nudge — Aurora, Colorado
- Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine — Halifax, Nova Scotia
- B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults — Birmingham, Alabama
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza — Anniston, Alabama
- Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants — Cincinnati, Ohio
Explore by condition: All Influenza clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.